Compliance with hormone therapy after Women's Health Initiative: Who is to blame?

Menopause

Volumn 12, Issue 4, 2005, Pages 363-365

  Pines, Amos ^a  

^a Department of Medicine T   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; SEX HORMONE;

BREAST ENGORGEMENT; CARDIOVASCULAR DISEASE; EDITORIAL; EDUCATION; ETHNOLOGY; FEAR; GASTROINTESTINAL HEMORRHAGE; GERMANY; HEART DISEASE; HORMONAL THERAPY; HOT FLUSH; HUMAN; MENOPAUSE; MOOD DISORDER; OSTEOPOROSIS; PATIENT COMPLIANCE; RELIGION; RISK BENEFIT ANALYSIS; SIDE EFFECT; SLEEP DISORDER; SOCIOECONOMICS; STROKE; UNITED STATES; VAGINA BLEEDING; WEIGHT GAIN; WELLBEING;

ATTITUDE OF HEALTH PERSONNEL; CROSS-CULTURAL COMPARISON; FEMALE; GERMANY; HEALTH EDUCATION; HORMONE REPLACEMENT THERAPY; HUMANS; INTERNET; MASS MEDIA; MENOPAUSE; PATIENT COMPLIANCE; PUBLIC OPINION; RANDOMIZED CONTROLLED TRIALS; UNITED STATES;

EID: 23244449956     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gme.0000165270.35239.5b     Document Type: Editorial

References (9)

1. Rolnick SJ, Kopher RA, DeFor TA, Kelly ME. Hormone use and patient concerns following the findings of the Women's Health Initiative. Menopause 2005;12:399-404.
2. Heitmann C, Greiser E, Doren M. The impact of the Women's Health Initiative Randomized Controlled Trial 2002 on perceived risk communication and use of postmenopausal hormone therapy in Germany. Menopause 2005;12:405-411.
3. MacLennan AH, Taylor AW, Wilson DH. Hormone therapy use after the Women's Health Initiative. Climacteric 2004;7:138-142.
4. Haskell SG. After the Women's Health Initiative: postmenopausal women's experiences with discontinuing estrogen replacement therapy. J Womens Health 2004;13:438-442.
5. Faulkner DL, Young C, Hutchins D, McCollam JS. Patient non-compliance with hormone replacement therapy: a nationwide estimate using a large prescription claims database. Menopause 1998;5:226-229.
6. Fistonic I, Srecko C, Marina F, Ivan S. Menopause in Croatia. Socio-demographic characteristics, women's attitudes and source of information, compliance with HRT. Maturitas 2004;47:91-98.
7. Kaplan B, Yogev Y, Orvieto R, Hirsch M, Fisher M, Rabinerson D. Effect of the WH1 study on the attitude of Israeli gynecologists to hormonal therapy during menopause. Clin Exp Obstet Gynecol 2004;31:267-268.
8. Simon JA, Wysocki S, Brandman J, Axelsen K. A comparison of therapy continuation rates of different hormone replacement agents: a 9-month retrospective, longitudinal analysis of pharmacy claims among new users. Menopause 2003;10:37-44.
9. Hayden M, Pignone M, Phillips C, Mulrow C. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the US. Ann Intern Med 2002;136:161-172.